» Articles » PMID: 37594630

Protease-independent Control of Parthanatos by HtrA2/Omi

Overview
Publisher Springer
Specialty Biology
Date 2023 Aug 18
PMID 37594630
Authors
Affiliations
Soon will be listed here.
Abstract

HtrA2/Omi is a mitochondrial serine protease with ascribed pro-apoptotic as well as pro-necroptotic functions. Here, we establish that HtrA2/Omi also controls parthanatos, a third modality of regulated cell death. Deletion of HtrA2/Omi protects cells from parthanatos while reconstitution with the protease restores the parthanatic death response. The effects of HtrA2/Omi on parthanatos are specific and cannot be recapitulated by manipulating other mitochondrial proteases such as PARL, LONP1 or PMPCA. HtrA2/Omi controls parthanatos in a manner mechanistically distinct from its action in apoptosis or necroptosis, i.e., not by cleaving cytosolic IAP proteins but rather exerting its effects without exiting mitochondria, and downstream of PARP-1, the first component of the parthanatic signaling cascade. Also, previously identified or candidate substrates of HtrA2/Omi such as PDXDC1, VPS4B or moesin are not cleaved and dispensable for parthanatos, whereas DBC-1 and stathmin are cleaved, and thus represent potential parthanatic downstream mediators of HtrA2/Omi. Moreover, mass-spectrometric screening for novel parthanatic substrates of HtrA2/Omi revealed that the induction of parthanatos does not cause a substantial proteolytic cleavage or major alterations in the abundance of mitochondrial proteins. Resolving these findings, reconstitution of HtrA2/Omi-deficient cells with a catalytically inactive HtrA2/Omi mutant restored their sensitivity against parthanatos to the same level as the protease-active HtrA2/Omi protein. Additionally, an inhibitor of HtrA2/Omi's protease activity did not confer protection against parthanatic cell death. Our results demonstrate that HtrA2/Omi controls parthanatos in a protease-independent manner, likely via novel, unanticipated functions as a scaffolding protein and an interaction with so far unknown mitochondrial proteins.

Citing Articles

Pathobiochemistry of Aging and Neurodegeneration: Deregulation of NAD+ Metabolism in Brain Cells.

Kolotyeva N, Groshkov A, Rozanova N, Berdnikov A, Novikova S, Komleva Y Biomolecules. 2025; 14(12.

PMID: 39766263 PMC: 11673498. DOI: 10.3390/biom14121556.

References
1.
van Loo G, van Gurp M, Depuydt B, Srinivasula S, Rodriguez I, Alnemri E . The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 2002; 9(1):20-6. DOI: 10.1038/sj.cdd.4400970. View

2.
Hegde R, Srinivasula S, Zhang Z, Wassell R, Mukattash R, Cilenti L . Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem. 2001; 277(1):432-8. DOI: 10.1074/jbc.M109721200. View

3.
Martins L, Iaccarino I, Tenev T, Gschmeissner S, Totty N, Lemoine N . The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J Biol Chem. 2001; 277(1):439-44. DOI: 10.1074/jbc.M109784200. View

4.
Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R . A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 2001; 8(3):613-21. DOI: 10.1016/s1097-2765(01)00341-0. View

5.
Faccio L, Fusco C, Chen A, Martinotti S, Bonventre J, Zervos A . Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J Biol Chem. 2000; 275(4):2581-8. DOI: 10.1074/jbc.275.4.2581. View